Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Mechanical Stress May Induce Formation of Cancer Cells

By LabMedica International staff writers
Posted on 25 Jul 2012
Researchers have developed a novel technique for studying the forces that induce mistakes in chromosome distribution that have the potential to initiate growth of cancer cells.

In order to study mechanical effects that influence the outcome of cell division, investigators at the University of California, Los Angeles (USA) developed a novel microfluidic perfusion-culture system that allowed controllable variation in the level of cell confinement in a single axis allowing observation of cell growth and division at the single-cell level.

This novel culture platform allowed for both alterations in the geometry of the microenvironment, specifically the space in which the cell was allowed to grow and divide, as well as the elasticity of the substrate on which the cell was dividing. More...
By using the microfluidic device to compress the cells, the investigators minimized cell death due to lack of nutrients, as media was constantly perfused through the compression chamber. The device also allowed for facile imaging of cells, as they were in a single focal plane.

The investigators used this tool to study growth and division of single HeLa (human cervical carcinoma) cells. They reported in the June 25, 2012, online edition of the journal PLoS ONE that mechanically confined cell cycles resulted in stressed cell divisions that manifested as: (i) delayed mitosis, (ii) multidaughter mitosis events (from three up to five daughter cells), (iii) unevenly sized daughter cells, and (iv) induction of cell death. In the highest confined conditions, the frequency of divisions producing more than two progeny was increased 50-fold from unconfined environments, representing about one-half of all successful mitotic events. Most daughter cells resulting from multipolar divisions were viable after cytokinesis and were in some cases observed to re-fuse with neighboring cells post-cytokinesis.

“We hope that this platform will allow us to better understand how the 3-D mechanical environment may play a role in the progression of a benign tumor into a malignant tumor that kills," said senior author Dr. Dino Di Carlo, associate professor of bioengineering at the University of California, Los Angeles. “Even though cancer can arise from a set of precise mutations, the majority of malignant tumors possess aneuploid cells, and the reason for this is still an open question. Our new microfluidic platform offers a more reliable way for researchers to study how the unique tumor environment may contribute to aneuploidy.”

Related Links:
University of California, Los Angeles




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.